-
This year, face masks are on most parents' list of back-to-school supplies. But which ones are most effective? Here's how to choose the right one for your child.
-
After vaccination, antibody levels can help predict how much protection a COVID-19 shot offers, scientists are learning. The finding could speed up the development of future vaccines.
-
In its final days, the Trump administration created a rule that could eliminate thousands of regulations created by the Department of Health and Human Services. A lawsuit is challenging the rule.
-
Katie Engelhart explores the complexity of physician-assisted death in the book The Inevitable. She says patients seeking to end their own lives sometimes resort to veterinary drugs from overseas.
-
The Code Breaker profiles Jennifer Doudna, a Nobel Prize-winning biochemist key to the development of CRISPR, and examines the technology's exciting possibilities and need for oversight.
-
In 1721, London was in the grips of a deadly smallpox epidemic. One woman learned how to stop it, but her solution sowed political division.
-
In Southern California, pollutants from wildfire smoke caused up to a 10% increase in hospital admissions. Researchers say there's a need for better air monitoring and public health programs.
-
As the pace of vaccination picks up, so do reports of spoiled doses. In Tennessee, close to 5,000 doses have been lost, prompting more oversight from state and federal officials.
-
Scientists are spotting new coronavirus variants almost on a daily basis. So far public health experts are still most worried about three important ones.
-
If you've been delaying routine medical care in the past year, now's the time to catch up, doctors say. The consequences of missing some key screenings and health checkups can be lethal.
-
People who have been sick with COVID-19 may need only one dose of the normally two-shot vaccines. If that became policy it could extend vaccine supplies, but logistical challenges are daunting.
-
Advisers to the Centers for Disease Control and Prevention voted to endorse the emergency use of a single dose of a vaccine made by Johnson & Johnson. A study showed it was 66% effective in the U.S.